Sotrastaurin, a Protein Kinase C Inhibitor, Ameliorates Ischemia and Reperfusion Injury in Rat Orthotopic Liver Transplantation
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2011.03700.x/fullpdf
Reference22 articles.
1. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation;Evenou;J Pharmacol Exp Ther,2009
2. Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation;Matz;Expert Opin Drug Metab Toxicol,2011
3. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720;Weckbecker;Transpl Int,2010
4. AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: A preliminary report;Fang;Transplant Proc,2010
5. The first-in-class oral protein kinase C inhibitor AEB071 prolongs renal allograft survival in nonhuman primates and suppresses lymphocyte proliferation at safe exposures in human proof-of-concept studies [abstract];Wagner;Transplant,2006
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury;Journal of Inflammation Research;2023-03
2. Protective Effect of Ebselen on Ischemia-reperfusion Injury in Epigastric Skin Flaps in Rats;ACTA HISTOCHEMICA ET CYTOCHEMICA;2022-10-28
3. Immune response associated with ischemia and reperfusion injury during organ transplantation;Inflammation Research;2022-10-25
4. Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same Coin;Journal of Clinical Medicine;2022-08-30
5. PPARγ Mediates Protective Effect against Hepatic Ischemia/Reperfusion Injury via NF-κB Pathway;Journal of Investigative Surgery;2022-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3